Why IMU is a multi multi bagger, page-20827

getting major players to enter the share register is dependant (i would say solely) on CF33 trial results, not on how desperately an IMU business developer holds their hand out. If results with an increased dosage are a lot more compelling than a mere single CR, major players might then contact IMU. And that is how it should be if you have something others want. Your expectations of interest or even the mentioning of BP at this very early stage seem premature, to the point of desperation. CF33 is not yet, or close to what we have been told it is and does.